文献速递临床试验与 GCP

分段枸橼酸钠溶液抗凝策略在接受CRRT的危重症患者中的应用研究:一项前瞻性随机对照研究

Study on the application of a segmented sodium citrate solution anticoagulation strategy in critically ill patients receiving CRRT: a prospective, randomized controlled study.
PubMed 文献 · Trials · 2024-08-16

该前瞻性随机对照研究纳入80例接受CRRT的危重症患者,比较分段枸橼酸钠溶液抗凝策略与常规抗凝策略。结果显示两组凝血、肝肾功能及SOFA、APACHE II评分无显著差异,实验组体外循环管路寿命为69.43±1.49小时,长于对照组的49.39±2.44小时(t=13.316,P=0.001)。

要点

  • 分段枸橼酸钠抗凝可延长体外循环管路寿命至69.43±1.49小时,对照组为49.39±2.44小时。
  • 两种枸橼酸钠溶液输注方式均维持外周循环通路低血钙浓度(0.25-0.45 mmol/L),无患者发生低钙血症(<1.0 mmol/L)。
  • 两组凝血指标、肝肾功能指标及SOFA、APACHE II评分无显著差异(P>0.05)。

核心结论

  • 分段枸橼酸钠溶液抗凝策略可延长体外循环管路寿命并提高CRRT疗效。

研究设计与样本

  • 前瞻性随机对照研究,纳入80例接受CRRT的危重症患者,随机分为两组。
  • 中国临床试验注册号ChiCTR2200057272,注册日期2022年3月5日。

主要发现

  • 两组凝血指标、肝功能指标、肾功能指标及SOFA和APACHE II评分无显著差异(P>0.05)。
  • 实验组静脉端口凝血等级低于对照组及两组滤器,但差异无统计学意义(P=0.337)。
  • 两种枸橼酸钠溶液输注方式均维持外周循环通路血钙浓度在0.25-0.45 mmol/L,无患者发生低钙血症(<1.0 mmol/L)。
  • 实验组体外循环管路寿命为69.43±1.49小时,对照组为49.39±2.44小时(t=13.316,P=0.001)。

关键数值与推荐

  • 实验组体外循环管路寿命69.43±1.49小时 vs 对照组49.39±2.44小时(t=13.316,P=0.001)。
  • 静脉端口凝血等级实验组低于对照组和两组滤器,差异无统计学意义(P=0.337)。
  • 两组凝血指标、肝功能指标、肾功能指标及SOFA和APACHE II评分无显著差异(P>0.05)。
  • 外周循环通路血钙浓度维持在0.25-0.45 mmol/L,无患者发生低钙血症(<1.0 mmol/L)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To explore the feasibility and effectiveness of a segmented sodium citrate solution anticoagulation strategy in patients receiving CRRT. METHODS: A prospective, randomized controlled study was conducted. RESULTS: According to the inclusion and exclusion criteria, 80 patients were included and randomly divided into two groups. Moreover, coagulation indices, liver function indices, renal function indices, and SOFA and APACHE II scores did not significantly differ between the two groups (P > 0.05). The coagulation grade of the venous ports in the experimental group was lower than that in the control group and the two groups of filters, but the difference was not statistically significant (P = 0.337). Both sodium citrate solution infusion methods maintained a low blood calcium concentration (0.25-0.45 mmol/L) in the peripheral circulation pathway, and no patient developed hypocalcaemia (< 1.0 mmol/L). The lifespans of the extracorporeal circulation tube in the experimental group and the control group were 69.43 ± 1.49 h and 49.39 ± 2.44 h, respectively (t = 13.316, P = 0.001). CONCLUSION: The segmented citrate solution anticoagulation strategy could extend the lifespan of the extracorporeal circulation tube and improve CRRT efficacy. TRIAL REGISTRATION: The Chinese Clinical Trial Registry number is ChiCTR2200057272. Registered on March 5, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen Y, Feng F, Guo H, et al. Study on the application of a segmented sodium citrate solution anticoagulation strategy in critically ill patients receiving CRRT: a prospective, randomized controlled study. Trials. 2024. PMID: 39152492. doi:10.1186/s13063-024-08370-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。